Pharmacoproteomics in drug development

被引:0
作者
Frank A Witzmann
Raymond A Grant
机构
[1] Indiana University School of Medicine,Department of Cellular and Integrative Physiology
[2] The Procter & Gamble Company,Corporate Research
来源
The Pharmacogenomics Journal | 2003年 / 3卷
关键词
drug development; mass spectrometry; protein array; protein interactions; proteomics; toxicology; two-dimensional electrophoresis;
D O I
暂无
中图分类号
学科分类号
摘要
The field of proteomics is taking on increased significance as the relevance of investigating and understanding protein expression in disease and drug development is appreciated. Recent advances in proteomics have been driven by the availability of numerous annotated whole-genome sequences and a broad range of technological and bioinformatic developments that underscore the complexity of the proteome. This review briefly addresses some of the various technologies that comprise Expression Proteomics and Functional Proteomics, citing examples where these emerging approaches have been applied to pharmacology, toxicology, and the development of drugs.
引用
收藏
页码:69 / 76
页数:7
相关论文
共 352 条
[1]  
Tew KD(1996)Glutathione-associated enzymes in the human cell lines of the national cancer institute drug screening program Mol Pharmacol 50 149-159
[2]  
Anderson L(1997)A comparison of selected mRNA and protein abundances in human liver Electrophoresis 18 533-537
[3]  
Seilhamer J(1999)Correlation between protein and mRNA abundance in yeast Mol Cell Biol 19 1720-1730
[4]  
Gygi SP(2001)Integrated genomic and proteomic analyses of a systematically perturbed metabolic network Science 292 929-934
[5]  
Rochon Y(2001)Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds Toxicology 160 129-138
[6]  
Franza BR(2000)Proteomics: applications and opportunities in preclinical drug development Electrophoresis 21 2099-2104
[7]  
Aebersold R(2002)Proteomic tools for biomedicine J Chromatogr B Analyt Technol Biomed Life Sci 771 33-48
[8]  
Ideker T(2002)The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis Biomarkers 7 269-290
[9]  
Thorsson V(2002)Proteomics: core technologies and applications in physiology Am J Physiol GI Liver Physiol 282 G735-G741
[10]  
Ranish JA(1998)Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis Electrophoresis 19 837-844